NOTICES 
30358 
[4110-08] 
RECOMBINANT DNA ADVISORY COMMITTEE 
Meeting 
Pursuant to Public Law 92-463, 
notice is hereby given of a meeting of 
the Recombinant DNA Advisory Com- 
mittee at the National Institutes of 
Health, Building 3 1C. conference room 
8, 9000 Rockville Pike, Bethesda, Md. 
20014, on August 2-3, 1978, from 9 a.m. 
to 5 p.m. 
The entire meeting will be open to 
the public for consideration of: 
Proposed revisions of NIH Guidelines for 
Research Involving Recombinant DNA 
Molecules. 
Organisms that exchange genetic informa- 
tion. 
Biological containment and safer host- 
vector systems. 
Review of protocols for required contain- 
ment levels. 
Requests for lowering of containment levels- 
on the basis of characterization of clones. 
Other matters requiring necessary action by 
the Committee. 
Attendance by the public will be lim- 
ited to space available. Dr. William J. 
Gartland, Executive Secretary. Re- 
combinant DNA Advisory Committee. 
National Institutes of Health. Building 
31, room 4A52, telephone 301-496- 
6051, will provide materials to be dis- 
cussed at the meeting, rosters of com- 
mittee members, and substantive pro- 
gram information. A summary of the 
meeting will be available at a later 
date. 
Dated: July 10. 1978. 
Suzanne L. Fremeau, 
Committee Management Officer, 
National Institutes of Health. 
CFR Doc. 78-19379 Filed 7-13-78; 8:45 am] 
[4110-08] 
SUBCOMMITTEES OF THE RECOMBINANT DMA 
ADVISORY COMMITTEE 
Meeting 
Pursuant to Pub. L. 92-463, notice is 
hereby given of a meeting of the Host- 
Plasmid Subcommittee and the Host- 
Phage Subcommittee of the Recom- 
binant DNA Advisory Committee at 
the National Institutes of Health. 
Building 31C. Conference Room 8. 
9000 Rockville Pike, Bethesda, Md. 
20014, on August 1, 1978, from 9 a.m. 
to 5 p.m. 
The entire meeting will be open to 
the public for discussion of the con- 
struction and testing of safer host- 
vector systems for recombinant DNA 
research, and other matters requiring 
consideration by the Subcommittees. 
Attendance by the public will be limit- 
ed to space available. 
Dr. William J. Gartland, Executive 
Secretary, Recombinant DNA Adviso- 
ry Committee, National Institutes of 
Health, Building 31. Room 4A52, tele- 
phone 301-496-6051, will provide mate- 
rials to be discussed at the meeting, 
rosters of committee members, and 
substantive program information. A 
summary of the meeting will be availa- 
ble at a later date. 
Dated: July 10, 1978. 
Suzanne L. Fremeau, 
Committee Management Officer, 
National Institutes of Health. 
[FR Doc. 78-19380 Filed 7-13-78; 8:45 ami 
FEDERAL REGISTER, VOL. 43, NO. 134 — FRIDAY, JULY 14, 197B 
[ 596 ] 
